A detailed history of Russell Investments Group, Ltd. transactions in Chimerix Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 32,600 shares of CMRX stock, worth $31,622. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,600
Previous 32,600 -0.0%
Holding current value
$31,622
Previous $34,000 17.65%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$0.94 - $1.23 $253 - $332
-270 Reduced 0.82%
32,600 $31,000
Q2 2023

Aug 10, 2023

SELL
$1.1 - $1.54 $89,158 - $124,821
-81,053 Reduced 71.15%
32,870 $39,000
Q1 2023

May 09, 2023

SELL
$1.19 - $2.09 $348,316 - $611,749
-292,703 Reduced 71.98%
113,923 $143,000
Q4 2022

Feb 08, 2023

BUY
$1.67 - $2.35 $324,818 - $457,079
194,502 Added 91.69%
406,626 $756,000
Q3 2022

Nov 04, 2022

BUY
$1.81 - $2.76 $127,047 - $193,729
70,192 Added 49.45%
212,124 $409,000
Q2 2022

Jul 29, 2022

BUY
$1.34 - $5.34 $65,705 - $261,841
49,034 Added 52.78%
141,932 $294,000
Q1 2022

May 05, 2022

SELL
$4.58 - $6.8 $187,976 - $279,092
-41,043 Reduced 30.64%
92,898 $424,000
Q4 2021

Jan 21, 2022

BUY
$5.23 - $7.18 $87,267 - $119,805
16,686 Added 14.23%
133,941 $860,000
Q3 2021

Nov 08, 2021

SELL
$5.94 - $8.75 $314,142 - $462,752
-52,886 Reduced 31.08%
117,255 $724,000
Q2 2021

Aug 04, 2021

SELL
$7.54 - $9.79 $486,013 - $631,043
-64,458 Reduced 27.48%
170,141 $1.36 Million
Q1 2021

May 10, 2021

BUY
$4.76 - $11.25 $851,130 - $2.01 Million
178,809 Added 320.5%
234,599 $2.26 Million
Q4 2020

Feb 08, 2021

SELL
$2.43 - $5.42 $7,003 - $15,620
-2,882 Reduced 4.91%
55,790 $269,000
Q3 2020

Nov 09, 2020

SELL
$2.3 - $3.72 $5,342 - $8,641
-2,323 Reduced 3.81%
58,672 $145,000
Q2 2020

Aug 05, 2020

SELL
$1.33 - $3.63 $90,301 - $246,462
-67,896 Reduced 52.68%
60,995 $188,000
Q4 2019

Jan 29, 2020

SELL
$1.3 - $2.72 $780 - $1,632
-600 Reduced 0.46%
128,891 $260,000
Q3 2019

Nov 01, 2019

BUY
$1.93 - $4.21 $103,581 - $225,946
53,669 Added 70.78%
129,491 $305,000
Q2 2019

Aug 09, 2019

BUY
$2.05 - $4.32 $138,780 - $292,455
67,698 Added 833.31%
75,822 $327,000
Q1 2019

May 13, 2019

SELL
$1.79 - $3.12 $88,825 - $154,823
-49,623 Reduced 85.93%
8,124 $18,000
Q4 2018

Feb 11, 2019

SELL
$2.24 - $3.9 $11,200 - $19,500
-5,000 Reduced 7.97%
57,747 $148,000
Q3 2018

Oct 26, 2018

SELL
$3.58 - $4.9 $53,700 - $73,500
-15,000 Reduced 19.29%
62,747 $244,000
Q2 2018

Aug 08, 2018

SELL
$4.43 - $5.14 $79,297 - $92,006
-17,900 Reduced 18.71%
77,747 $370,000
Q1 2018

May 11, 2018

BUY
$4.65 - $5.9 $38,130 - $48,380
8,200 Added 9.38%
95,647 $497,000
Q4 2017

Feb 06, 2018

BUY
$4.32 - $5.52 $25,056 - $32,015
5,800 Added 7.1%
87,447 $411,000
Q3 2017

Nov 07, 2017

BUY
$4.35 - $5.25 $355,164 - $428,646
81,647
81,647 $428,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.